The preclinical trial, led by Professor Maziar Divangahi, uncovered that beta-glucan, also present in yeast, can “reprogramme” immune cells to prevent lung inflammation.

Credits: envato elements; Author: DC_Studio;

His team demonstrated that administering the compound to mice before their exposure to influenza, reduced lung damage, improved lung function, and lowered the risk of illness and death.